| Vol. 13.23 – 14 June, 2022 |
| |
|
|
| Mechanistically, reticulocalbin-2 binds to a functional receptor complex, which is composed of neuronilin-2 and integrin beta-1, to activate a cAMP-PKA signaling pathway that mobilizes bone marrow fat via lipolysis to fuel the differentiation and function of mesenchymal and hematopoietic stem cells. [Cell Metabolism] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| In combination with adeno-associated virus serotype 6 template delivery, the authors’ approach led to efficient HDR in human hematopoietic stem and progenitor cells and T cells, with minimal NHEJ-mediated on-target mutations. [Science Advances] |
|
|
|
| Scientists comprehensively mapped the naked mole rat hematopoietic landscape and identified unique features likely contributing to longevity. [EMBO Journal] |
|
|
|
| Researchers showed that, in the absence of CLASP2, a microtubule-associated protein, the overall production of hematopoietic stem cells (HSCs) was reduced, and the produced HSCs failed to self-renew and maintain their stemness throughout mouse and zebrafish development. [Cell Reports] |
|
|
|
| Scientists demonstrated that Fbxw11 plays a negative role in the maintenance of hematopoietic stem/progenitor cells in vitro and repopulation capacity in vivo. [Stem Cell Research & Therapy] |
|
|
|
| Investigators identified three miRNAs, miR-146a-5p, miR-181b-5p, and miR-199b-3p, as potential candidates for TLR8 ligation, which are overexpressed in acute lymphoblastic leukemia and show agonist functional binding. [Journal of Leukocyte Biology] |
|
|
|
| The authors demonstrated that human committed hematopoietic progenitors could be reprogrammed into multipotent progenitors by spliceosome inhibitor. [Experimental Hematology & Oncology] |
|
|
|
| Using conditional in vivo models of steady state and acute Padi4 ablation, researchers examined the role of PADI4 in the development and function of the hematopoietic system. [Biology Open] |
| |
|
|
| Scientists investigated the longitudinal dynamics of the gut microbiota and metabolome and potential associations to clinical outcomes in pediatric hematopoietic stem cell transplantation at a single center. [Microbiome] |
|
|
|
|
| Researchers summarize current knowledge on the cellular composition of the human bone marrow niche after hematopoietic cell transplantation. [Bone Marrow Transplantation] |
|
|
|
|
| Nammi Therapeutics, Inc. announced that the FDA has granted orphan drug designation to its lead program, QXL138AM, for the treatment of multiple myeloma. [Nammi Therapeutics, Inc. (Cision US Inc.)] |
|
|
|
| bluebird bio, Inc. announced the outcome of the FDA Cellular, Tissue, and Gene Therapies Advisory Committee discussion of betibeglogene autotemcel (beti-cel) for the treatment of people with beta-thalassemia who require regular red blood cell transfusions. [bluebird bio, Inc.] |
|
|
|
| Centogene N.V. announced that it has expanded its long-standing PYRUKYND® partnership with Agios Pharmaceuticals, Inc. Agios’ PYRUKYND® is a selective, small molecule activator of the pyruvate kinase enzyme. [Centogene N.V.] |
|
|
|
|
| October 3 – 5 Vancouver, British Columbia, Canada |
|
|
|
|
|
| American Association for Cancer Research – Various, United States |
|
|
|
| Francis Crick Institute – London, England, United Kingdom |
|
|
|
| Albert Einstein College of Medicine – New York, New York, United States |
|
|
|
| Van Andel Institute – Grand Rapids, Michigan, United States |
|
|
|
| Columbia University – New York, New York, United States |
|
|
|
|